TCR2 Therapeutics Inc.
ENGINEERED T CELLS FOR THE TREATMENT OF CANCER
Last updated:
Abstract:
Provided herein are T-cell receptor (TCR) fusion proteins (TFPs), T cells engineered to express one or more TFPs, and methods of use thereof for the treatment of diseases, including cancer.
Status:
Application
Type:
Utility
Filling date:
21 Dec 2017
Issue date:
24 Jun 2021